SiRNAs-A New Class of Medicines
Overview
Authors
Affiliations
A Facile and Promising Delivery Platform for siRNA to Solid Tumors.
Leng Q, Anand A, Mixson A Molecules. 2024; 29(23.
PMID: 39683699 PMC: 11643702. DOI: 10.3390/molecules29235541.
siRNAEfficacyDB: An experimentally supported small interfering RNA efficacy database.
Zhang Y, Yang T, Yang Y, Xu D, Hu Y, Zhang S IET Syst Biol. 2024; 18(6):199-207.
PMID: 39541343 PMC: 11665841. DOI: 10.1049/syb2.12102.
Multispecies-targeting siRNAs for the modulation of JAK1 in the skin.
Tang Q, Gross K, Fakih H, Jackson S, Zain U I Abideen M, Monopoli K Mol Ther Nucleic Acids. 2024; 35(1):102117.
PMID: 38304729 PMC: 10831156. DOI: 10.1016/j.omtn.2024.102117.
Recent advances in exosomal non-coding RNA-based therapeutic approaches for photoaging.
Li K, Zhou P, Guo Y, Xu T, Lin S, Lin S Skin Res Technol. 2023; 29(9):e13463.
PMID: 37753673 PMC: 10495620. DOI: 10.1111/srt.13463.
Badri P, Habtemariam B, Melch M, Clausen V, Arum S, Li X Clin Pharmacokinet. 2023; 62(10):1509-1522.
PMID: 37639169 DOI: 10.1007/s40262-023-01292-w.